Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

J&J joins in on industry price hiking; almost 500 drug prices increased in 2019 so far

January 11, 2019 Medical Communications, Sales and Marketing J&J, JJ, Stelara, US, Xarelto, Zytiga, pharma, price hikes

It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …
News

Foundation medicine name Roche SVP as new CEO

January 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the …
Appointment

NICE rejects Novartis’ Aimovig migraine injection for NHS use

January 10, 2019 Sales and Marketing Aimovig, NICE, Novartis, migraine, pharma

It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …
News

Amgen and UCB’s Evenity approved in Japan for osteoporosis

January 9, 2019 Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …
News

bluebird bio reveals new UK General Manager

January 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …
Appointment

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Appointment

Immunocore names AstraZeneca exec as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
Appointment

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
Appointment

Roche’s Genentech inks potential $2bn personalised cancer drug development deal

January 7, 2019 Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma

Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …
News

How tech is powering precision treatment

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Feature

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019 Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …
News

AstraZeneca loses two senior executives as biotechs appoint new CEOs

January 7, 2019 Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …
News

$400 billion in healthcare M&A deals expected for 2019

January 7, 2019 Sales and Marketing Hong Kong, M&A, MA, biotech, deals pharma, law, mergers

The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …
News

Sanofi will pay Regeneron $582m in deal restructuring

January 7, 2019 Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …
News

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019 Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026